Cervical cancer is the second most common cancer among women in India. Most cases are caused by the Human Papillomavirus (HPV). Health experts worldwide recommend vaccinating girls at age 14 because it provides the best protection before they are exposed to the virus later in life.

In early 2026, the United States faced a serious measles outbreak across 26 states. This happened because some groups of people had stopped taking routine vaccinations (like the MMR vaccine). This situation serves as a warning for other countries like India about the dangers of not following vaccination schedules.

The government is taking extra care by allowing vaccinations only in government hospitals with trained staff. This is to monitor people for ‘Adverse Events Following Immunisation’ (AEFI). If someone feels unwell after the shot, these teams are ready to provide immediate medical help, which builds public confidence in the vaccination program.

The World Health Organization (WHO) confirmed in 2022 that a single dose of the HPV vaccine is very effective for young people. This is helpful for India because it makes the vaccination drive cheaper and easier to manage compared to programs that require two or three shots.

Human Papillomavirus (HPV) has many varieties, but most are harmless. However, ‘high-risk’ types like 16 and 18 are responsible for roughly 70-80% of cervical cancer cases worldwide. This is why medical science focuses on vaccines that specifically target these two versions of the virus.

In India, about 80% of cervical cancer is caused by HPV strains 16 and 18. This means that if we can successfully vaccinate girls against these two types, we could potentially prevent the majority of future cervical cancer cases in the country.

Vaccination prevents the virus from starting, but regular ‘screening’ (tests like Pap Smears) helps find early signs of cancer in people who are already infected. Using both vaccination and screening is the best way to eliminate the disease.

Many countries, including the United Kingdom and Australia, have already moved to a single-dose schedule for the HPV vaccine. This trend follows scientific research which shows that one dose is enough to protect young girls, making health programs more efficient.

Australia was one of the first countries to start a nationwide HPV vaccine program in schools. As a result, they have seen a massive decrease in HPV-related diseases and are on track to eliminate cervical cancer entirely by 2035. This gives India a successful model to follow.

Most cancers cannot be prevented by a vaccine. Cervical cancer is special because it is almost always caused by a virus (HPV). This means we can use a vaccine to stop the virus and, therefore, stop the cancer from ever developing. This is why it is of ‘great preventive value’.

The WHO divides the world into six regions. In the South-East Asia Region (SEARO), India is the largest country and faces the biggest challenges. Because India reports 65% of the region’s cervical cancer cases, any improvement here will significantly boost health in the whole of South-Asia.

Cervical cancer is the second leading cause of cancer deaths among women in India. The sheer numbers (almost 80,000 deaths a year) show that this is a major public health emergency that needs vaccines to prevent it.

In India, most women do not have access to or awareness of cervical cancer screening (like the Pap Smear). Because very few women (under 2%) are being tested, most cancers are found too late. This is why a vaccination program to stop the cancer before it begins is critical.

Around 2009, India tried an HPV vaccine project in Andhra Pradesh and Gujarat. Unfortunately, it became very controversial because of ethical issues and the deaths of some girls. This ‘dark past’ makes people even today feel some doubt about the HPV vaccine.

The 2009 trial involved thousands of girls in experimental programs. When seven of them died, it led to a public outcry and the program was halted. Many parents in India still remember this event, which creates some fear about the new vaccine drive.

The ICMR checked the old deaths and said they were likely due to other reasons (like malaria or snake bites). However, because they couldn’t be 100% sure in every case, it left some doubt in the public’s mind. This is why the sentence says the cause wasn’t ‘established with certainty’.

In old vaccine trials, some health issues after shots (AEFI) were not reported correctly. This led to serious problems. Now, the government is being warned that every single reaction must be studied carefully to make sure the program succeeds and people feel safe.

The ‘cold chain’ is critical for vaccines; if they get too warm, they stop working. To successfully implement a nationwide program, the government must also be ‘transparent’ (not hide anything) and ‘meticulous’ (being very careful) in reporting side effects. This builds the public’s trust and ensures the vaccine’s safety.